---
schema_version: "secwatch.filing_event.v1"
accession: "0000937556-25-000029"
form_type: "8-K"
ticker: "MASI"
cik: "0000937556"
company_name: "MASIMO CORP"
filed_at: "2025-02-25T23:59:59+00:00"
generated_at: "2026-05-26T05:20:18.925281+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Masimo Q4 revenue $601M (+9%); Non-GAAP EPS $1.80 (+44%); FY2025 guide sees healthcare growth 8-11%

## Summary
- Q4 revenue $601M (+9% YoY); Healthcare $368M (+8%), Non-healthcare $232M (+11%).
- GAAP net loss per share ($6.52) due to Sound United impairment; Non-GAAP diluted EPS $1.80 (+44%).
- Full-year 2024 healthcare revenue $1,395M (+9%); Non-healthcare revenue $699M (-10%).
- FY2025 guidance: Healthcare revenue $1.50B-$1.53B (8-11% constant currency), Non-GAAP EPS $5.10-$5.40.
- New CEO Katie Szyman cites strong healthcare momentum and record customer contracts in 2024.

## SEC filing metadata
- accession: 0000937556-25-000029
- form_type: 8-K
- ticker: MASI
- cik: 0000937556
- company_name: MASIMO CORP
- filed_at: 2025-02-25T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/937556/000093755625000029/0000937556-25-000029-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/937556/000093755625000029/masi-20250225.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000937556-25-000029
- JSON: https://secwatch.observer/filing/0000937556-25-000029.json
- Plain text: https://secwatch.observer/filing/0000937556-25-000029.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.